People · Operator
Named in public records as an officer, director or promoter · active 2023–2025 · Other Technology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Foro Holdings, Inc. | — | Other Technology | Series A | $12.7M | $32.6M | 2025 |
| Telomir Pharmaceuticals, Inc. | — | Pharmaceuticals | Pre-Seed | $1.0M | $9.7M | 2023 |
David Vorhoff at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Vorhoff on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Johnson | 1 | 22 |
| Richard Thompson | 1 | 17 |
| Craig Eagle | 1 | 4 |
| JAMES MCNULTY | 1 | 3 |
| Jude Uzonwanne | 1 | 3 |
| Chris Chapman | 1 | 2 |
| Hugh Reed McColl III | 1 | 1 |
| Tuck Talhia | 1 | 1 |
| Hugh McColl | 1 | 1 |
| Rohit Mathur | 1 | 1 |
| Lizzie Hartley | 1 | 1 |
| David Reed Godsman | 1 | 1 |
| Mark Reed Johnson | 1 | 1 |
| Dave Reed Vorhoff | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.